revascularization

FFR Post Angioplastia

Complex Coronary Angioplasty in Elderly Patients: Problem or Solution?

Cardiovascular disease is the leading cause of death in elderly adults (individuals aged 75&nbsp;years or older). In turn, coronary heart disease is one of the main causes of morbidity in this population. In addition to anatomical complexities, there are other factors that may complicate its management, such as polypharmacy, frailty, and procedure-related risks. All of<a href="https://solaci.org/en/2023/10/18/complex-coronary-angioplasty-in-elderly-patients-problem-or-solution/" title="Read more" >...</a>

Resonancia vs FFR en lesiones no culpables del infarto

Cardiac Angiography: Necessary for CABG Patient Diagnosis?

Cardiac revascularization surgery (CABG) has shown positive results at long term in CAD patients with multivessel or left main disease. However, we are well aware that, after CABG, there might be native disease progression over time. Also, at followup, we often see high incidence of venous graft failure.&nbsp; According to registry data, approximately 1 in<a href="https://solaci.org/en/2023/10/12/cardiac-angiography-necessary-for-cabg-patient-diagnosis/" title="Read more" >...</a>

Left Main Coronary Artery PCI: In What Scenario Could We Not Use IVUS?

Lesions in the left main coronary artery (LMCA) continue to pose a significant challenge. The use of coronary imaging before percutaneous coronary implantation (PCI) has proven useful in analyzing the lesion, identifying the presence and location of calcification, and determining lesion length in the LMCA, the left anterior descending artery, and the circumflex artery. Various<a href="https://solaci.org/en/2023/10/10/left-main-coronary-artery-pci-in-what-scenario-could-we-not-use-ivus/" title="Read more" >...</a>

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejas

Treatment and Gender-Based Outcomes for Coronary Bifurcation Stent Placement: Report from the e-ULTIMASTER Registry

Approximately 20% of all percutaneous coronary interventions (PCI) are performed on bifurcation lesions, which continue to pose a challenge in terms of strategy: how many stents to use, what is the most suitable strategy, and when to transition from a single stent to two during the procedure. Additionally, the use of two stents in these<a href="https://solaci.org/en/2023/10/06/treatment-and-gender-based-outcomes-for-coronary-bifurcation-stent-placement-report-from-the-e-ultimaster-registry/" title="Read more" >...</a>

indicación de tratamiento con estatinas

Anti-Lipid Therapy in PCI Patients: Monotherapy with Statins or Combination?

According to several studies, in patients with high-risk atherosclerotic disease, such as those affected by coronary artery disease, achieving target LDL levels through high-intensity statin therapy has been shown to lead to a significant reduction in long-term cardiovascular events. Therefore, the management of dyslipidemia has become a fundamental pillar of secondary prevention. However, reaching such<a href="https://solaci.org/en/2023/10/04/anti-lipid-therapy-in-pci-patients-monotherapy-with-statins-or-combination/" title="Read more" >...</a>

POKI: una nueva estrategia en bifurcaciones

BIFURCAT Registry: 1 or 2 Stents? Treatment of Side Branch (Medina 0.0.1) Lesions According to Real-World Data

Coronary bifurcation lesions have been a subject to debate, with different approaches by various medical teams. These lesions often carry a higher risk of ischemic events compared with lesions at non-bifurcated sites. The main strategy, supported by medical society recommendations and clinical guidelines, involves using provisional stenting with one stent to minimize the number of<a href="https://solaci.org/en/2023/10/04/bifurcat-registry-1-or-2-stents-treatment-of-side-branch-medina-0-0-1-lesions-according-to-real-world-data/" title="Read more" >...</a>

TAVI: Balón expandible o autoexpandible ¿Cuál es la respuesta?

Use of Drug-Coated Balloons in De Novo Lesions in Large Coronary Vessels

Drug-coated balloon (DCB) angioplasty is emerging as a novel treatment for coronary artery disease. Studies evaluating this strategy have demonstrated clinically non-inferior outcomes compared with those of drug-eluting stent (DES) implantation in patients with in-stent restenosis and de novo disease in small vessels. However, evidence for the use of DCBs in large coronary vessels is<a href="https://solaci.org/en/2023/09/28/use-of-drug-coated-balloons-in-de-novo-lesions-in-large-coronary-vessels/" title="Read more" >...</a>

Dietas bajas en carbohidratos y progresión de la calcificación coronaria

Coronary Artery Calcium on Non–ECG-Gated Chest CTs: Mere Finding or Therapeutic Opportunity?

CAD related acute phenomena often present as a consequence of poor risk factor monitoring over time. Early detection of these patients, especially high risk patients, has significantly contributed to reducing morbimortality over time.&nbsp; Coronary artery calcification (CAC) is considered a measure of atherosclerosis burden in and might be present in asymptomatic individuals. Most centers do<a href="https://solaci.org/en/2023/09/26/coronary-artery-calcium-on-non-ecg-gated-chest-cts-mere-finding-or-therapeutic-opportunity/" title="Read more" >...</a>

Nueva y discrepante información sobre los vasos no culpables en el infarto

Prognostic Impact of SYNTAX and SYNTAX II Scores in Patients with Acute Myocardial Infarction

Acute myocardial infarction (AMI) continues to be a clinically significant condition due to its association with morbidity and mortality after the initial event. Therefore, the prognostic stratification of these patients is of vital importance. One of the tools that have been used for several years for this purpose is the SYNTAX I (SS) and SYNTAX<a href="https://solaci.org/en/2023/09/25/prognostic-impact-of-syntax-and-syntax-ii-scores-in-patients-with-acute-myocardial-infarction/" title="Read more" >...</a>

Fentanilo en la angioplatia: ¿Cuál es el precio de un mayor confort en el procedimiento?

Substudy TALOS AMI: from Ticagrelor to Clopidogrel in Patients with High Risk of Bleeding and AMI

The preference for the use of potent P2Y12 inhibitors such as ticagrelor and prasugrel in patients with high risk of acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is based on randomized studies and current guideline recommendations. However, clopidogrel is still recommended for patients at high risk of bleeding. Several strategies have been looked<a href="https://solaci.org/en/2023/09/20/substudy-talos-ami-from-ticagrelor-to-clopidogrel-in-patients-with-high-risk-of-bleeding-and-ami/" title="Read more" >...</a>

Top